EpiNet UK All articles
Care coordination

A Subject Worth Naming: Approaching SUDEP in a Neurology Review

EpiNet UK

Sudden unexpected death in epilepsy (SUDEP) is one of the most difficult subjects in epilepsy care. It is also a subject many patients and carers have already met, perhaps through a charity leaflet, an online forum or a passing comment in a clinic. The difficulty is not usually that SUDEP is unknown. It is that it can feel too frightening to name. A measured conversation, handled at the right pace, can make the subject more manageable rather than more alarming. In 2026, UK epilepsy services are increasingly encouraged to discuss SUDEP as part of routine review, not as a single dramatic announcement but as part of ongoing care.

Why the subject comes up in review

SUDEP refers to the sudden, unexpected death of a person with epilepsy when no other cause is found at post-mortem. It is uncommon, but it is important. Research suggests that the risk is higher in people whose generalised tonic-clonic seizures are not well controlled, particularly when those seizures happen during sleep. That does not mean every person with epilepsy is at high risk, and it does not mean a single seizure predicts SUDEP. It means that seizure control, night-time safety and medicine review are worth discussing carefully.

Some clinicians once avoided the topic for fear of causing distress. The thinking has shifted. Many UK epilepsy teams now see SUDEP as part of a broader safety conversation: not a prediction, not a verdict, but an opportunity to review what can be changed and what support is available. The aim is neither false reassurance nor fatalism. It is honest, proportionate information that respects the patient and the family.

What is known, and what is not

Evidence about SUDEP is evolving. The strongest consistent message is that uncontrolled generalised tonic-clonic seizures are associated with greater risk. Sleep-related seizures, missed doses of anti-seizure medicine, abrupt withdrawal of medicine and high alcohol intake have also been identified as areas of concern. Some people have seizures that are difficult to control despite good care; in that situation, the conversation should focus on support and realistic planning rather than blame.

What cannot be offered is a reliable individual prediction. No score or checklist can tell a person exactly what will happen. Tools such as the SUDEP and Seizure Safety Checklist, used by some UK services, are designed to structure a discussion and identify modifiable factors. They are aids to conversation, not crystal balls. A calm clinician will say what is known, acknowledge uncertainty and explain why certain steps are worth considering.

Preparing for the conversation

It can help to arrive with a few notes. Record the seizure types you or the person you care for experience, roughly how often they occur, and whether they happen at night. Note any recent medicine changes, missed doses, sleep disruption or alcohol use. These details help the clinician tailor the discussion. It is also reasonable to ask who will be present and whether a carer or family member can join, especially if they witness seizures that the patient does not remember.

If the subject is raised unexpectedly, you can ask to slow down. You might say that you would like to understand the reason for the discussion and whether it can be continued at the next appointment. A good team will not insist on covering everything in one sitting. Some people prefer written information to take away; others prefer to talk it through with a specialist nurse. Both are valid.

Questions worth asking

A useful conversation is usually one in which questions are welcome. Consider asking:

It is also acceptable to say that you do not wish to discuss SUDEP today. The subject can be revisited. What matters is that the door is left open and that information is not withheld indefinitely.

Practical steps without blame

The most constructive message is that risk reduction is a shared process. Reviewing anti-seizure medicines with the epilepsy team, taking them consistently and not stopping them abruptly are central. Sleep matters; regular rest and attention to known triggers can support seizure control. Alcohol deserves an honest conversation rather than a lecture. Night-time safety may include bedroom arrangements, supervision where appropriate, or seizure detection devices, but these should be discussed with an understanding of their limitations. No device or routine removes all risk.

A seizure action plan can help families know what to do and when to seek urgent help. For some people, rescue medication may be part of the plan. For others, the priority may be reviewing medicine adherence or arranging a specialist appointment. These are clinical decisions, not moral tests. If a seizure occurs, the response should be support and review, not blame.

The emotional weight

Hearing about SUDEP can stay with people for days. Some feel frightened; others feel angry that the subject was not raised sooner. Carers may carry a particular burden, especially if seizures occur at night. It is reasonable to ask for a follow-up conversation, to request written information, or to speak with an epilepsy specialist nurse. SUDEP Action provides information and support, and can signpost to bereavement services where needed. Cruse Bereavement Support and local NHS psychological services may also be relevant for people struggling with anxiety or grief.

If a family has been bereaved by SUDEP, the conversation is different. Support should be gentle, practical and free from implied blame. Charities, GP services and specialist bereavement counselling can help. Coroner processes and post-mortem discussions may add to distress; clear explanation and a named contact can make those steps more bearable.

A conversation that continues

SUDEP is not a subject that needs to dominate every review. It is one thread in a wider plan that includes seizure control, medicine safety, sleep, emergency planning and emotional wellbeing. A single conversation is rarely enough. The best care tends to return to the subject over time, checking understanding and adjusting the plan as circumstances change.

If your team does not raise SUDEP, you are entitled to ask. A simple sentence can open the discussion: I would like to talk about SUDEP and what I can reasonably do to reduce risk. The answer should be calm, individual and honest. That is the standard worth expecting in 2026.

All Articles

Related Articles

Holding Steady Before the Review: A Practical Plan for the Neurology Waiting List

Holding Steady Before the Review: A Practical Plan for the Neurology Waiting List

Light, Pattern and Pace: A Calm Guide to Photosensitive Epilepsy and Screens in 2026

Light, Pattern and Pace: A Calm Guide to Photosensitive Epilepsy and Screens in 2026

A Single Seizure, a Structured Pathway: What UK First Seizure Clinics Assess in 2026

A Single Seizure, a Structured Pathway: What UK First Seizure Clinics Assess in 2026